Takara Bio Inc. (OTCMKTS:TKBIF) Short Interest Update

Takara Bio Inc. (OTCMKTS:TKBIFGet Free Report) saw a significant increase in short interest in November. As of November 15th, there was short interest totalling 26,600 shares, an increase of 84.7% from the October 31st total of 14,400 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is presently ∞ days.

Takara Bio Price Performance

TKBIF stock opened at $23.20 on Friday. The stock has a 50-day simple moving average of $23.20 and a two-hundred day simple moving average of $23.20. Takara Bio has a twelve month low of $23.20 and a twelve month high of $23.20.

About Takara Bio

(Get Free Report)

Takara Bio Inc, together with its subsidiaries, engages in bioindustry, contract development and manufacturing organization (CDMO), and gene therapy businesses in Japan, China, rest of Asia, the United States, Europe, and internationally. The company sells reagents and instruments, including genetic research reagents and testing kits; products related to coronavirus testing comprising in vitro diagnostics that detect viruses; analytical reagents; single-cell analysis systems; gene expression research reagents; fluorescent proteins series; genome-editing research reagents; iPS cell research reagents; and products for stem cell culturing and induction of differentiation under the TaKaRa, Clontech, and Cellartis brand names.

Read More

Receive News & Ratings for Takara Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Takara Bio and related companies with MarketBeat.com's FREE daily email newsletter.